You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
凱普生物(300639.SZ):公司及子公司獲得1項發明專利授權
格隆匯 12-02 16:05

格隆匯12月2日丨凱普生物(300639.SZ)公佈,公司以及子公司在2024年11月獲得1項發明專利授權,發明專利名稱為一種從孕婦宮頸脱落細胞中分離胎盤滋養層細胞的方法。

該發明專利公開了一種從孕婦宮頸脱落細胞中分離胎盤滋養層細胞的方法,該方法基於滋養層細胞表面或胞內表達的特異性抗原及組合,並利用設計的微流控分選芯片或流式細胞儀,對孕婦宮頸脱落細胞樣本所製備的細胞懸浮液進行分選,從而獲得純化的胎盤滋養層細胞。本發明與傳統方法相比,具有無創穫取標本和特異性好的優勢,該方法取材時間較傳統檢測方法更早,可能引起的感染及流產的風險更低,能實現同時對多個抗原進行同步標記,並對多個特徵信號進行識別和分選。該方法提高了檢測的準確性,檢測結果具有更高的可信度和更廣的覆蓋範圍。本發明將應用於產前篩查和產前診斷領域,目前已取得中國、美國、日本、俄羅斯、巴西、韓國、澳大利亞以及歐洲等國家或地區頒發的發明專利證書,是公司細胞分選項目的首個成果。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account